PAIM
DMK

Punch & Associates Investment Management’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Punch & Associates Investment Management’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-6
Closed -$2.16K – 245
2015
Q4 		$2.16K Buy
+6
New +$1.88K ﹤0.01% 253

Other funds holding DMK

SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Punch & Associates Investment Management's DMK Position: Q1 2016 in Review

Punch & Associates Investment Management sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2016, closing a stake of 6 shares — an estimated $2.16K sold.

Punch & Associates Investment Management first reported a position in DMK in Q4 2015 and held it in 1 quarter. The position peaked at $2.16K in Q4 2015. 28 funds tracked by Wall St. Rank hold DMK as of Q1 2016.

  • Punch & Associates Investment Management reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2016 after selling out during the quarter.
  • Punch & Associates Investment Management sold 6 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2016, an estimated $2.16K.
  • Punch & Associates Investment Management first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q4 2015 and held it in 1 quarter.
  • Punch & Associates Investment Management's DMK Pharmaceuticals Corporation Common Stock position peaked at $2.16K in Q4 2015.
  • 28 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2016.

Based on Punch & Associates Investment Management's 13F filing for Q1 2016, filed 25 Apr 2016.